Gjestad et al. reply to 'Was 4β-hydroxycholesterol ever going to be a useful marker of CYP3A4 activity?' by Neuhoff and Tucker

Br J Clin Pharmacol. 2018 Jul;84(7):1624-1625. doi: 10.1111/bcp.13606. Epub 2018 May 10.

Authors

Caroline Gjestad¹, Tore Haslemo¹, Ole A Andreassen^{2

3}, Espen Molden^{1

4}

Affiliations

¹ Center for Psychopharmacology, Diakonhjemmet Hospital, Oslo, Norway.
² NORMENT, KG Jebsen Centre for Psychosis Research, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
³ Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
⁴ Department of Pharmaceutical Biosciences, School of Pharmacy, University of Oslo, Oslo, Norway.

No abstract available

Keywords: 4β-hydroxycholesterol; CYP3A4; quetiapine.

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Biomarkers
Cytochrome P-450 CYP3A
Humans
Hydroxycholesterols*
Quetiapine Fumarate

Substances

Biomarkers
Hydroxycholesterols
cholest-5-ene-3,4-diol
Quetiapine Fumarate
Cytochrome P-450 CYP3A
CYP3A4 protein, human